Дезодоранты и флюорография: в Челябинской области развеяли мифы о раке груди
Дезодоранты и флюорография: в Челябинской области развеяли мифы о раке груди Pchela.News
Онкология
🎗️Лента новостей
Онкология
HLB resubmits FDA bid for first-line liver cancer combo after fixes - CHOSUNBIZ
HLB resubmits FDA bid for first-line liver cancer combo after fixes - CHOSUNBIZ Chosunbiz
Онкология
Звезда «Дома-2» из Владивостока Алена «Рапунцель» Савкина сообщила о раке
Звезда «Дома-2» из Владивостока Алена «Рапунцель» Савкина сообщила о раке VladNews
🎗️
Онкология
HLB Completes FDA Resubmission for First-Line Liver Cancer Treatment
HLB Completes FDA Resubmission for First-Line Liver Cancer Treatment 아시아경제
Онкология
When Cancer Treatment Consumes Life: Lymphoma Patients Reveal the Hidden Burden of Time Toxicity
When Cancer Treatment Consumes Life: Lymphoma Patients Reveal the Hidden Burden of Time Toxicity Bioengineer.org
:format(jpg)/YXJ0aWNsZXMvaW1hZ2UvMjAyNi8xMC9wb2xpa2xpbmlrYS1wcmllbS12cmFjaGEtMjBfNEcwVnU0Wi5qcGc.jpg)
Онкология
Связь лишнего веса и рака: пояснения онколога
Связь лишнего веса и рака: пояснения онколога REGIONS.ru
Онкология
Maesteg teen whose cancer returned after remission has clinical trial hope
Maesteg teen whose cancer returned after remission has clinical trial hope BBC
Онкология
Maesteg teen whose cancer returned after remission has clinical trial hope
Maesteg teen whose cancer returned after remission has clinical trial hope BBC
Онкология
Why Head and Neck Cancer Rehab Trials Must Stratify for Lymphoedema
Why Head and Neck Cancer Rehab Trials Must Stratify for Lymphoedema Bioengineer.org
Онкология
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond Oncodaily
Онкология
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer BioPharma APAC
Онкология
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer
Akeso Initiates Phase III Trial of Cadonilimab for Resectable MSI-H/dMMR Colon Cancer BioPharma APAC
Онкология
Suman Karanth: Strengthening Global Collaboration to Advance Oncology Clinical Trials
Suman Karanth: Strengthening Global Collaboration to Advance Oncology Clinical Trials Oncodaily
Онкология
Two Approved Companion Diagnostics Validate Pembrolizumab Eligibility Across dMMR/MSI-H Tumors
Two Approved Companion Diagnostics Validate Pembrolizumab Eligibility Across dMMR/MSI-H Tumors Bioengineer.org
Онкология
Wafik S. El-Deiry: Precision Oncology and Molecular Tumor Board Insights From the 2026 WIN Symposium
Wafik S. El-Deiry: Precision Oncology and Molecular Tumor Board Insights From the 2026 WIN Symposium Oncodaily